METABOLIC EXPLORER |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.163 EUR | +1.24% |
|
-5.78% | -57.99% |
| Mar. 20 | METabolic EXplorer: Noovistago on the road to reorganization | CF |
| Mar. 12 | METabolic EXplorer: applies for safeguard proceedings | CF |
Chart calendar METabolic EXplorer
241b1157b599c3cef.0AIwCdLT2ykYvCabKY-oKwJppm-j0PCo18Eku4P00L8.qWcFReeejH1a72_UQPn9UmEl7S3OpaiFtpFK-cKRqdngWH8_vLbjalLYFg~6d67f3edd983cbc5444b19c9fc6d0f16
Upcoming events on METabolic EXplorer
Past events on METabolic EXplorer
| 2024-03-27 | Q4 2023 Earnings Release |
| 2024-02-14 | Q4 2023 Sales and Revenue Release |
| 2023-11-08 | Q3 2023 Sales and Revenue Release |
| 2023-09-27 | Q2 2023 Earnings Release |
| 2023-07-26 | Q2 2023 Sales and Revenue Release |
| 2023-06-08 | Shareholders Meeting |
| 2023-05-03 | Q1 2023 Sales and Revenue Release After hours |
| 2023-03-29 | Q4 2022 Earnings Release |
| 2023-02-08 | Rights Issue: 5 new shares @ 1.13 EUR for 31 existing shares |
| 2022-11-07 | Q3 2022 Sales and Revenue Release |
| 2022-09-29 | Interim 2022 Earnings Release |
| 2022-07-27 | Interim 2022 Sales and Revenue Release |
| 2022-06-09 | Shareholders Meeting |
| 2022-05-04 | Q1 2022 Sales and Revenue Release |
| 2022-03-30 | FY 2021 Earnings Release |
| 2022-02-02 | FY 2021 Sales and Revenue Release |
| 2021-11-08 | Q3 2021 Sales and Revenue Release |
| 2021-09-29 | Interim 2021 Earnings Release |
| 2021-07-28 | Interim 2021 Sales and Revenue Release |
| 2021-06-27 | Shareholders Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3,31 3,50 -5.49% | 0,35 5,40 -93.52% | 1,90 3,20 -40.63% | 172 171 0.45% | 228 229 -0.15% |
|
EBITDA Million EUR | Released Forecast Spread | -3,03 -1,50 -101.87% | 0,00 0,00 - | 0,00 0,00 - | -6,70 -8,60 22.09% | -29,8 -29,7 -0.37% |
|
EBIT Million EUR | Released Forecast Spread | -4,64 -2,60 -78.42% | -8,09 -5,20 -55.58% | -10,6 -7,20 -47.18% | -14,3 -17,6 18.55% | -42,9 -34,9 -22.92% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -5,23 -4,38 -19.36% | 0,00 0,00 - | 0,00 0,00 - | 73,5 68,6 7.13% | 0,00 0,00 - |
|
Net income Million EUR | Released Forecast Spread | -6,14 -3,20 -91.75% | -8,25 -5,40 -52.69% | -8,94 -7,30 -22.49% | 84,1 -15,6 639.22% | -50,8 -43,4 -17.13% |
|
EPS EUR | Released Forecast Spread | -0,26 -0,19 -36.84% | 0,00 0,00 - | -0,33 0,00 - | 2,07 -0,36 680.25% | -1,16 -0,99 -17.17% |
| Announcement Date | 29/03/19 | 30/03/20 | 29/03/21 | 31/03/22 | 30/03/23 |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 S1 |
|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 62,3 62,2 0.11% | 129 129 0.05% |
|
EBITDA Million EUR | Released Forecast Spread | -7,40 -1,50 -393.33% | |
| Announcement Date | 30/09/22 | 30/09/22 |
More events
Past sector events for METabolic EXplorer
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- METEX Stock
- Calendar METabolic EXplorer
